Urology and Nephrology Center, The First Bethune Hospital of Jilin University, Xinmin Street 71, Changchun, Jilin 130021, China.
Bosn J Basic Med Sci. 2013 Aug;13(3):170-4. doi: 10.17305/bjbms.2013.2357.
The aim of our study was to investigate the expression of kidney injury molecule-1 (KIM-1) in renal allograft biopsy samples and assess the clinical significance of its use as a biomarker for tissue damage. A total of 69 renal allograft biopsy samples from 17 patients with normal serum creatinine and 52 cases of increased serum creatinine were collected. They were divided into different groups according to the Banff 2007 diagnostic criteria. KIM-1 expression was detected by immunohistochemical methods and the association of KIM-1 and blood biochemical indexes was analyzed. KIM-1 expression increased as Banff 2007 classification grade increased and was positively correlated with tubular inflammation severity in the acute T-cell rejection group. Moreover, KIM-1 expression was strongly positive in the chronic active antibody-mediated rejection group. Interestingly, KIM-1 was weakly positive in the normal group without obvious acute rejection and injury of immunosuppressant toxicity. In this group, 27.3% (3/11) of the cases with normal serum creatinine level showed weakly positive KIM-1 expression in their renal tissues. KIM-1 expression level is positively correlated with renal allograft damage and tubular cell injury. KIM-1 is expressed in tubular epithelial cells before blood biochemical indexes become elevated and morphological changes occur. KIM-1 expression is an early, sensitive, and specific biomarker to determine renal tubular epithelial cell injury in renal allograft tissue.
本研究旨在探讨肾损伤分子-1(KIM-1)在肾移植活检样本中的表达,并评估其作为组织损伤生物标志物的临床意义。共收集了 17 例血清肌酐正常和 52 例血清肌酐升高的患者的 69 例肾移植活检样本。根据 Banff 2007 诊断标准将其分为不同组。采用免疫组织化学方法检测 KIM-1 的表达,并分析 KIM-1 与血液生化指标的相关性。结果显示,KIM-1 的表达随着 Banff 2007 分类等级的增加而增加,与急性 T 细胞排斥组肾小管炎症严重程度呈正相关。此外,在慢性活动性抗体介导的排斥反应组中,KIM-1 的表达呈强阳性。有趣的是,在没有明显急性排斥反应和免疫抑制剂毒性损伤的正常组中,KIM-1 呈弱阳性。在该组中,血清肌酐水平正常的 11 例患者中有 27.3%(3/11)的患者其肾组织中 KIM-1 呈弱阳性表达。KIM-1 表达水平与肾移植损伤和肾小管细胞损伤呈正相关。在血液生化指标升高和形态学改变发生之前,KIM-1 就在肾小管上皮细胞中表达。KIM-1 表达是判断肾移植组织肾小管上皮细胞损伤的早期、敏感、特异性生物标志物。